Showing results (101-110 of 118) with videos related to

Sort By:
Pageof 12
The Journal of Experimental Medicine|December 1, 2010
Preferential infection and depletion of Mycobacterium tuberculosis-specific CD4 T cells after HIV-1 infectionChristof Geldmacher, Njabulo Ngwenyama, Alexandra Schuetz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 27, 2015
A Blueprint to Address Research Gaps in the Development of Biomarkers for Pediatric TuberculosisMark Patrick Nicol, Devasena Gnanashanmugam, Renee Browning, et al.
BMC Infectious Diseases|May 17, 2020
Ultrasound in managing extrapulmonary tuberculosis: a randomized controlled two-center studyRobert Ndege, Omary Ngome, Farida Bani, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 27, 2024
Evaluation of C-Reactive Protein and Computer-Aided Analysis of Chest X-rays as Tuberculosis Triage Tests at Health Facilities in Lesotho and South AfricaShannon Bosman, Irene Ayakaka, Josephine Muhairwe, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 4, 2022
Ultrasononography in Managing Extrapulmonary Tuberculosis: A Randomized, Controlled, Parallel, Superiority, Open-Label TrialRobert Ndege, Omary Ngome, Fiona Vanobberghen, et al.
Lancet (London, England)|March 22, 2015
Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label, partly randomised trial in patients with drug-susceptible or drug-resistant pulmonary tuberculosisRodney Dawson, Andreas H Diacon, Daniel Everitt, et al.
Plos One|December 10, 2014
Safety and immunogenicity of H1/IC31®, an adjuvanted TB subunit vaccine, in HIV-infected adults with CD4+ lymphocyte counts greater than 350 cells/mm3: a phase II, multi-centre, double-blind, randomized, placebo-controlled trialKlaus Reither, Lynn Katsoulis, Trevor Beattie, et al.
The Lancet. Respiratory Medicine|November 17, 2019
Bedaquiline, moxifloxacin, pretomanid, and pyrazinamide during the first 8 weeks of treatment of patients with drug-susceptible or drug-resistant pulmonary tuberculosis: a multicentre, open-label, partially randomised, phase 2b trialConor D Tweed, Rodney Dawson, Divan A Burger, et al.
Open Forum Infectious Diseases|July 28, 2026
Prevalence and Mortality due to Mycobacterium tuberculosis Bloodstream Infection in Adults With HIV: A Multicountry Prospective Cohort StudyBianca Sossen, Madalo Mukoka, Rita Székely, et al.
The Lancet. Global Health|November 22, 2024
Urine-Xpert Ultra for the diagnosis of tuberculosis in people living with HIV: a prospective, multicentre, diagnostic accuracy studyBianca Sossen, Rita Székely, Madalo Mukoka, et al.
Pageof 12